Our research addresses complex public policy challenges, primarily in developing countries. We work with many different kinds of stakeholders—governments, multinational corporations, multilaterals, non-profits, and foundations.
This 2018 white paper reflects on PPPI’s Case Development Program and on our series of Healthcare PPP Forums in China and Singapore. It touches on many key issues, including the necessity of case-based curricula for teaching PPP. The paper centers on three key recommendations involving the convergence of NCDs and eldercare, a flexible PPP model, and capacity-building for PPPs.Download in English
This 2015 study was researched and published during PPP Initiative’s affiliation with Johns Hopkins University’s School of Advanced International Studies. Over the course of 18 months, a research team lead by Professor Trager and principal researcher Molly Guan identified China and India’s varying constraints and abilities to leverage PPP, using a data-driven approach. The study found that the two countries faced many similar challenges and three key hurdles: execution, financing and innovation.
The Eli Lilly Foundation provided funding for the research and preparation of the Mapping Study.Download in English Download in Chinese
Amgen, Inc. supported an independent research project by PPP Initiative Ltd. to create a set of healthcare PPP case studies that would have specific relevance to Asia. The case studies aim to be the definitive model for building PPP capacity in China and beyond. The Case Study Program included five forums: two in Beijing; two in Singapore and one in Washington D.C.
A case study about China’s recovery from a catastrophic earthquake in 2008 (58,000 people were injured or dead in two minutes).
A case study about a city medical park formed as a PPP in Shanghai.
A case study about the transformation of the Boston Archdiocese Hospital System as a result of a $900 million private equity transaction and the recruitment of a Harvard Medical School cardiovascular surgeon as CEO.